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Abstract1
Clinical studies have used CD4 T cell counts to evaluate the safety or risk of2
plasma HIV-1 RNA-guided structured treatment interruptions (STIs), aimed at3
maintaining CD4 T cell counts above a safe level and plasma HIV-1 RNA below a4
certain level. However, quantifying and evaluating the impact of STIs on the5
control of HIV replication and on activation of the immune response remains6
challenging. Here we extend the virus-immune dynamic system by including a7
piecewise smooth function to describe the elimination of HIV viral loads and the8
activation of eﬀector cells under plasma HIV-1 RNA-guided therapy, in order to9
quantitatively explore the STI strategies. We theoretically investigate the global10
dynamics of the proposed Filippov system. Our main results indicate that HIV11
viral loads could either go to infinity or be maintained below a certain level or12
stabilize at a previously given level, depending on the threshold level and initial13
HIV virus loads and eﬀector cell counts. This suggests that proper combinations of14
threshold and initial HIV virus loads and eﬀector cell counts, based on threshold15
policy, can successfully preclude exceptionally high growth of HIV virus and, in16
particular, maximize the controllable region.17
Keywords Structured treatment interruptions; Filippov system; sliding mode;18
pseudo-equilibrium19
2
1 Introduction1
Highly active antiretroviral therapy (HAART) has been shown to significantly2
improve survival and reduce morbidity in HIV patients (Palella et al., 1998;3
Mocroft et al., 1998). However, long-term HAART continues to be associated with4
many problems such as adherence diﬃculties and the evolution of drug resistance5
(Zhang et al., 1999; Carr et al., 1999; Harrington and Carpenter, 2000; Johnson et6
al., 2004). Structured therapy interruptions (STIs) have been suggested as being7
capable of achieving sustained specific immunity for early therapy in HIV8
infection. As an alternative strategy, STI is a good choice for some chronically9
infected individuals who may need to take drugs throughout their lives, and it is10
beneficial for the patients’ immune reconstruction during the period when they are11
not taking the drugs (Maggiolo et al., 2009). Therefore, drug therapies targeted at12
boosting a virus specific immune response have attracted more and more attention.13
Recently, several clinical studies have been aimed at comparing STI strategies14
with continuous antiretroviral therapy, but conflicting results have been reported15
(Maggiolo et al., 2009; Ruiz et al., 2007; EL-Sadr et al., 2006; Anaworanich et al.,16
2006; Guerrero et al., 2005; Hadjiandreou et al., 2009; Lori et al., 2000; Maggiolo et17
al., 2004). In particular, Ruiz et al. (Ruiz et al., 2007) designed an experiment to18
evaluate the safety of CD4 cell counts and plasma HIV-1 RNA-guided structured19
treatment interruptions (STIs) aiming to maintain CD4 T cell counts higher than20
350 cells/µl and plasma HIV-1 RNA less than 100,000 copies/µl. They concluded21
that STIs were not as safe as continuing therapy. Although many mathematical22
models have been formulated to model continuous therapy(Kuznetsov et al., 1994;23
Blower et al., 2000; Rong et al., 2007; Tian and Liu, 2014), few attempts have been24
made to model structured treatment interruptions. In 2012, the authors (Tang et25
al., 2012) proposed a piecewise system to describe the CD4 cell count-guided STIs,26
to quantitatively explore STI strategies and to investigate their dynamic27
behaviors, which explained some controversial conclusions from diﬀerent clinical28
studies. To the authors’ best knowledge, no mathematical model has yet been29
3
proposed to model a plasma HIV-1 RNA-guided structured treatment strategy. An1
additional challenge remains regarding examination of whether the virus-guided2
structured treatment can successfully maintain plasma HIV-1 RNA below a certain3
level or not, and to determine under what conditions patients are suitable for4
structured treatment interruptions. Quantifying these issues through a5
mathematical modeling framework is the main objective of this study.6
The purpose of the study is to propose a mathematical model to describe plasma7
HIV-1 RNA-guided structured treatment, and examine the eﬃcacy of this8
treatment for maintaining plasma HIV-1 RNA below a certain level. The paper is9
organized as follows. In the next section, we propose our model, provide the10
definitions for our Filippov system of the virus-immune system and describe the11
main dynamics of two subsystems. Then the sliding domain and the sliding12
dynamics are discussed in section 3. In section 4, we investigate the global13
dynamics of the proposed system. Finally, the biological meaning and the14
concluding remarks are discussed in section 5.15
2 Model equations and preliminaries16
The virus dynamic system was formulated to investigate the interaction between17
the virus and the eﬀector cells (Pugliese and Gandolfi, 2008; Boer and Perelson,18
1998). The model equations without considering density dependent inhibition of19
the virus are as follows20 ⎧⎪⎨⎪⎩ x˙ = rx− βxy,y˙ = ρxy
1+ωx
− µxy − δy,
(1)
where x and y represent the HIV viral loads and the density of eﬀector cells,21
respectively and r is the growth rate of HIV virus which incorporates both22
multiplication and death of HIV virus, δ is the death rate of the eﬀector cells, β23
denotes the rate of binding of the eﬀector cells to the HIV viruses. As shown in24
(Abrahms and Brahmi , 1988; Callewaert et al., 1988; Komarova et al., 2003; Shu25
et al., 2014), the eﬀector cells seem to have a limited ability to repeatedly kill26
4
target cells during the interaction of the eﬀector cells and target cells, which shows1
the inactivation of eﬀector cells. Here, let µ represent the rate of inactivation of2
the eﬀector cells. Note that that when the virus load is low, the level of immune3
response is simply proportional to both the viral load, x, and the density of4
eﬀector cells, y. However, eﬀector cell multiplication due to immune response has a5
maximum value as HIV viral load gets suﬃciently large. Therefore, it is reasonable6
to suggest the nonlinear form ρxy/(1 + ωx) to model this (Shu et al., 2014).7
Based on the above virus dynamic system (1), we model the plasma HIV-18
RNA-guided therapy in order to maintain the amount of virus below a certain9
level and to activate the immune system. To this end, whenever the virus load10
exceeds a critical level (or threshold level Tc), antiretroviral drugs are applied to11
inhibit growth of the virus, and simultaneously interleukin (IL)-2 treatment is used12
to activate the immune response (e.g., promote maturation and cytotoxicity of13
CD4 cells (eﬀector cells))(Marchetti et al., 2005; Napolitano, 2003). Hence the14
HIV virus dynamic system with HIV-1 RNA-guided therapy can be described15
following piecewise model16 ⎧⎪⎨⎪⎩ x˙ = rx− βxy − ε1Ψx,y˙ = ρxy
1+ωx
− µxy − δy + ε2Ψy
(2)
with17
Ψ =
⎧⎪⎨⎪⎩ 0, if H(x) = x− Tc < 0,1, if H(x) = x− Tc > 0, (3)
and parameter ε1 represents the rate of elimination of HIV virus due to18
antiretroviral therapy and ε2 denotes the growth rate of the eﬀector cells due to19
interleukin (IL)-2 treatment.20
System (2) with (3), a particular form of a Filippov system, can also be21
theoretically investigated by using a general dynamical method but this requires22
complicated and elaborate mathematical techniques (see details in (Kuznetsov et23
al., 2003; Bernardo et al,, 2008; Padmanabhan and Singh, 1995)). The following24
definitions on all types of equilibria of non-smooth system (2) with (3) are25
necessary throughout the rest of this paper.26
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Let R2+ = {X = (x, y)|x ≥ 0, y ≥ 0}, S1 = {X ∈ R2+|H(X) < 0}, and1
S2 = {X ∈ R2+| H(X) > 0} with H(X) as a smooth scale function. Moreover, the2
discontinuity boundary Σ separating the two regions is described as3
Σ = {X ∈ R2+| H(X) = 0}.
It is easy to see that R2+ = S1
⋃
Σ
⋃
S2. Consider the following generic planar4
Filippov system5
X˙ =
⎧⎪⎨⎪⎩ FS1(X), X ∈ S1,FS2(X), X ∈ S2, (4)
and denote6
σ(X) = 〈HX(X), FS1(X)〉〈HX(X), FS2(X)〉,
where 〈·, ·〉 is the standard scalar product and HX(X) represents the gradient of7
H(X) which is non-vanishing on Σ. Then the sliding mode domain is defined as8
ΣS = {X ∈ Σ|σ(X) ≤ 0}.
In what follows we will use the notation Fsi ·H(X) = 〈HX(X), FSi(X)〉 for i = 1, 2.9
Definition 1. A point X∗ is called a regular equilibrium of system (4) if10
FS1(X
∗) = 0, H(X∗) < 0 or FS2(X
∗) = 0, H(X∗) > 0; A point X∗ is called a11
virtual equilibrium of system (4) if FS1(X
∗) = 0, H(X∗) > 0 or FS2(X
∗) = 0,12
H(X∗) < 0.13
Definition 2. A point X∗ is called a pseudo-equilibrium if it is an equilibrium14
of the sliding mode of system (4), i.e. λFS1(X
∗) + (1− λ)FS2(X∗) = 0, H(X∗) = 015
with 0 < λ < 1 and16
λ =
〈HX(X∗), FS2(X∗)〉
〈HX(X∗), FS2(X∗)− FS1(X∗)〉
.
A point X∗ is called a boundary equilibrium of system (4) if FS1(X
∗) = 0,17
6
H(X∗) = 0 or FS2(X
∗) = 0, H(X∗) = 0.1
Definition 3. A point X∗ is called a Σ−contact point of system (4) if X∗ ∈ ΣS2
and [Fs1 ·H(X∗)][Fs2 ·H(X∗)] = 0. A Σ−contact point X∗ is called a Σ−fold point3
of FS1 if FS1 ·H(X∗) = 0 but F 2s1 ·H(X∗) = 0. Moreover, X∗ is called a visible4
(invisible) Σ−fold point of FS1 if FS1 ·H(X∗) = 0 but F 2S1 ·H(X∗) > 05
(F 2s1 ·H(X∗) < 0). We call X∗ a Σ−fold point of the system (4) if it is a Σ−fold6
point either of FS1 or of FS2.7
3 Dynamics of two subsystems8
For convenience, we call the Filippov system (2) with (3) defined in the region S19
as subsystem S1, and the system defined in the region S2 as subsystem S2.10
Moreover, we assume that ρ− µ− δω > 2√µδω, δ > ε2 and r > ε1 hold true11
throughout this work, which guarantee that subsystem S1(S2) exists two positive12
equilibria, denoted by E11 = (x11, y11) and E12 = (x12, y12)(E21 = (x21, y21) and13
E22 = (x22, y22)), respectively. Here for i = 1, 2 we have14
x1i =
ρ− µ− δω ∓
√
(ρ− µ− δω)2 − 4µδω
(2µ
, y1i =
r
β
and15
x2i =
ρ− µ− (δ − ε2)ω ∓
√
(ρ− µ− (δ − ε2)ω)2 − 4µ(δ − ε2)ω
2µ
, y2i =
r − ε1
β
.
Thus, we have the following conclusions on the existence and stability of the16
equilibria of the two subsystems.17
Proposition 1. For the subsystem S1 (S2) there exists a trivial equilibrium18
E10 = (0, 0) (E20 = (0, 0)) which is a saddle point; The subsystem S1 (S2) has two19
positive equilibria E11 (E21) which is a center, and E12(E22) which is a saddle20
point. Also, there exists a homoclinic orbit with respect to E12 (E22), denoted as21
7
Γ1S1 ( Γ
1
S2
).1
The topological structure of the orbits of the both subsystems is shown in Fig.1.2
From which we can see that there is an intersection point of the homoclinic orbit3
Γ1S1 (Γ
1
S2
) with the line y = r/β (y = (r − ε1)/β), which is denoted by4
E13 = (x13, r/β) (E23 = (x23, (r − ε1)/β)).5
Lemma 1. The horizontal components of four positive equilibria of the two6
subsystems satisfy x21 < x11 < x12 < x22.7
Proof. Consider the function8
f(z) = ρ− µ− ωz −
√
(ρ− µ− ωz)2 − 4µωz.
By simple calculations we have f ′(z) > 0 if and only if ρ− z > −1. Thus, the9
function f(z) is strictly monotonically increasing when z < ρ+ 1. It follows from10
the existence conditions of the positive equilibria of the two subsystems that11
ρ− (δ − ε2) > ρ− δ > µβ > −1. Therefore, x11 > x21 always holds true. Further,12
we can verify that x12 < x22 is always true whenever they exist. This completes13
the proof.14
According to the definitions above, we have that if Tc < x21, then both the15
equilibria E21 and E22 are regular equilibria while E11 and E12 are virtual16
equilibria. As Tc increases and exceed x21, then the equilibrium E21 becomes a17
virtual equilibrium. If Tc continuously increases and crosses x11, equilibrium E1118
becomes a regular equilibrium while the equilibrium E12 becomes a regular19
equilibrium too when Tc > x12. Furthermore, if Tc > x22 holds true, the20
equilibrium E22 is a virtual equilibrium. Therefore, if we let the parameter Tc vary21
and fix all other parameters we have five diﬀerent types of the regular/virtual22
equilibria of system (2) with (3) which are shown in Table 1.23
If we consider the subsystem S1 in the phase space, then y can be seen as a24
function of x with the following diﬀerential equation25
8
dy
dx
=
y
x
ρx
1+ωx
− µx− δ
r − βy ,
and integrating above equation from (x1, y1) to (x, y), one yields1
∫ x
x1
(
ρ
1 + ωx
− µ− δ
x
)
=
∫ y
y1
(
r
y
− β
)
.
That is, the first integral H1(x, y) of subsystem S1 is as follows2
H1(x, y) = − ρ
ω
ln(1 + ωx) + δ ln(x) + µx+ r ln(y)− βy = h1, (5)
where h1 = H1(x1, y1) is a constant. Similarly, the subsystem S2 also has the3
following first integral4
H2(x, y) = − ρ
ω
ln(1 + ωx) + (δ − ε2) ln(x) + µx+ (r − ε1) ln(y)− βy = h2 (6)
with constant h2 = H2(x2, y2).5
Thus, according to the definition of the Lambert W function (Appendix A) and6
solving H1(x, y) = h1 with respect to y, one yields two roots7
yS1l = − rβW
[
0,−β
r
exp
(
ρ ln(1+ωx)−δω ln(x)−µωx+h1ω)
rω
)]
(7)
and8
yS1u = − rβW
[
−1,−β
r
exp
(
ρ ln(1+ωx)−δω ln(x)−µωx+h1ω)
rω
)]
. (8)
Similarly, solving H2(x, y) = h2 with respect to y, one has9
yS2l = − r−ε1β W
[
0,− β
r−ε1
exp
(
ρ ln(1+ωx)−(δ−ε2)ω ln(x)−µωx+h2ω)
(r−ε1)ω
)]
(9)
and10
yS2u = − r−ε1β W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωx)−(δ−ε2)ω ln(x)−µωx+h2ω)
(r−ε1)ω
)]
. (10)
In order to show that ySil and y
Si
u (i = 1, 2) are well defined, the domains of the11
Lambert W function and its properties are used, which have been addressed in12
detail in Appendix A.13
9
4 Basic properties of Filippov system (2)1
Based on the definitions and discussions in section 2, the interior of the sliding2
domain can be defined as3
intΣs = {X ∈ Σ| σ(X) < 0}
and according to the definition of σ(X) we have4
σ(X) = (rx− βxy)(rx− βxy − ε1x).
Solving the inequality σ(X) < 0, one yields (r − ε1)/β < y < r/β.5
Therefore, the sliding mode domain of Filippov system (2) with (3) can be6
defined as7
ΣS =
{
(x, y) ∈ R2+| x = Tc,
r − ε1
β
≤ y ≤ r
β
}
.
Denote A = (Tc, r/β), B = (Tc, (r − ε1)/β), which are the two end-points of sliding8
segment ΣS. By simple calculation we have Fs1 ·H(A) = 0, F 2s1 ·H(A) > 0,9
Fs1 ·H(B) = 0 and F 2s1 ·H(B) > 0. Therefore A (B) is a Σ−fold point of10
subsystem S1 (S2) which is visible.11
Next, we employ Utkin’s equivalent control method introduced in (Utikin et al.,12
2009) to obtain the sliding dynamics in the region ΣS. It follows from H = 0 and13
the first equation of system (2) that14
dH
dt
=
dx
dt
= rx− βxy −Ψε1x = 0. (11)
Solving equation (11) with respect to Ψ yields15
Ψ =
r − βy
ε1
.
Substituting Ψ into the second equation of system (2) gives16
dy
dt
= y
(
−ε2β
ε1
y +
ε2r
ε1
+
ρTc
1 + ωTc
− µTc − δ
)
.
10
Therefore, the vector field of Filippov model (2) defined on the sliding domain1
can be described as follows:2
Z˙(t) = Fs(X), X ∈ intΣs,
where Fs(X) = (Ps(X), Qs(X)) with3
Qs(X) = y(−ε2βy/ε1 + ε2r/ε1 + ρTc/(1 + ωTc)− µTc − δ) and Ps(X) = 0.4
Therefore, the sliding mode dynamics are described by dy/dt = Qs(X). There5
exist two roots of Qs = 0 given as follows:6
y0 = 0, yc =
r
β
+
ε1
βε2
(
ρTc
1 + ωTc
− µTc − δ
)
.
Theorem 1 If x21 ≤ Tc ≤ x11 or x12 ≤ Tc ≤ x22 holds true, then there exists7
one and only one pseudo-equilibrium Ec = (Tc, yc) of Filippov system (2) with (3),8
which is stable on the sliding domain ΣS. Further, if Tc = x21 (x11, x12, x22) holds9
true, then the positive equilibrium E21 (E11, E12, E22), the boundary point B (A, A,10
B) and the pseudo-equilibrium Ec will coincide into together.11
Proof. Define the function
g1(x) =
ρx
1 + ωx
− µx− δ.
According to Proposition 1 if ρ− µ− δω > 2√µδω, then there would be two12
positive roots of the equation g(x) = 0, which are x11 and x12. Simple analysis13
shows that if x11 < x < x12, then g1(x) > 0; If x < x11 or x > x12, then g1(x) < 0.14
This indicates that if Tc < x11 or Tc > x12 then yc < r/β; If x11 < Tc < x12 then15
yc > r/β.16
Rearranging yc yields17
yc =
r − ε1
β
+
ε1
βε2
(
ρTc
1 + ωTc
− µTc − δ + ε2
)
.
Similarly, we can define the function18
g2(x) =
ρx
1 + ωx
− µx− δ + ε2.
11
Again from Proposition 1 if x21 < x < x22 then g2(x) > 0; If x21 < x or x > x221
then g2(x) < 0. This implies that if x21 < Tc < x22 then yc > (r − ε1)/β; If2
x21 < Tc or Tc > x22 then yc < (r − ε1)/β.3
Based on the above discussions, if x21 < Tc < x11 or x12 < Tc < x22, then we4
have (r − ε1)/β < yc < r/β. That is, when x21 < Tc < x11 or x12 < Tc < x22, then5
Ec = (Tc, yc) is a pseudo-equilibrium of system (2) with (3).6
Moreover, it is easy to have7
dQs
dy
∣∣∣∣∣
(Tc,yc)
= −ε2β
ε1
Tc < 0,
which shows that the pseudo-equilibrium Ec is locally stable on the sliding domain8
ΣS whenever it exists.9
Therefore, if we choose Tc = x21, then the boundary point B will coincide with10
the equilibrium E21 according to the definition of the sliding domain. Moreover,11
when Tc = x21, then g2(x) = 0 (i.e. yc = (r − ε1)/β) holds true. Therefore, the12
boundary point B of the sliding domain will also coincide with the13
pseudo-equilibrium Ec when Tc = x21. Thus, the three points including the14
boundary point B, the positive equilibrium E21 and the pseudo-equilibrium Ec15
coincide into one point as Tc = x21. A similar thing happens for Tc = x11, Tc = x1216
and Tc = x22. This completes the proof.17
5 Global analysis of Filippov system (2)18
In this section we discuss the global dynamics of Filippov system (2) with (3). It is19
interesting to note that here an important curve, which consists of some orbits of20
system (2) and/or of some segments of orbits of system (2), can be defined to21
identify the diﬀerent dynamic behaviours. In order to define this key curve22
denoted by Υ and examine the global dynamics of Filippov system (2), we consider23
three diﬀerent cases: (a) Tc < x23; (b) Tc > x22; and (c) x23 < Tc < x22.24
Case (a): Tc < x23. For this case there must be an orbit Γ
4 of subsystem S225
tangent to x = Tc at point B shown in Fig.2. Let Γ
4
u and Γ
4
l represent the upper26
12
and lower branches of the orbit Γ4, respectively. According to the topological1
structure of the subsystems, we have that there must be an orbit of subsystem S12
initiating from B, denoted as Γ5, and it intersects with line x = Tc at another3
point E4 = (Tc, y4). It follows from the first integral of subsystem S1 and equation4
(8) that y4 can be calculated as5
y4 = − rβW
[
−1,−β
r
exp
(
ρ ln(1+ωTc)−δω ln(Tc)−µωTc+h11ω)
rω
)]
(12)
with h11 = H1(Tc, r/β).6
Similarly, there should exist an orbit of the subsystem S2 passing through the7
point E4, and we denote it as Γ
6. Therefore, the curve Υ can be defined as8
Γ6 ∪ Γ5 ∪ Γ4u in this case. Define the region inside the curve Υ as DΥ, the region9
inside the orbit Γ4 as DΓ4 and the region inside the homoclinic orbit Γ
1
Si
(i = 1, 2)10
as DΓ1
Si
(i = 1, 2).11
Moreover, the orbits initiating from DΓ4 can not reach the line x = Tc, and12
hence are free from switching. Therefore, the equilibrium E21 is a regular13
equilibrium which is locally stable within the region DΓ1
S2
. The orbits of subsystem14
S2 starting from the region DΓ4 \DΓ1
S2
will tend to (∞, 0), shown in Fig.2. Then,15
we consider the orbits inside the curve Υ (i.e. in DΥ). All orbits starting from the16
region DΥ either directly reach the segment BA or enter into the region S1 by17
crossing the segment AE4, then follows the dynamics of subsystem S1, and finally18
reaches the segment BA. Furthermore, any trajectory initiating from the segment19
BA slides down and approaches point B due to dy/dt = QS < 0. Therefore all the20
orbits initiating from the region DΥ will approach the point B and finally tend to21
(∞, 0) along Γ4l .22
It follows from Fig.2 that any orbit starting from the region above the curve Υ23
initially reaches the switching line on {(Tc, y) : y > y4}, enters the region S1 and24
follows the dynamics of subsystem S1, then crosses the switching line again on25
{(Tc, y) : 0 < y < (r − ε1)/β} and enters S2 finally tending to (∞, 0) along the26
dynamics of subsystem S2. Based on the above discussion, we have the following27
13
conclusion.1
Theorem 2 If Tc < x23 holds true, then the equilibrium E21 is a center and2
locally stable in DΓ1
S2
. All other orbits initiating from R2+ \DΓ1
S2
will tend to3
(∞, 0). The global attractor of the Filippov system (2) is DΓ1
S2
∪ {(∞, 0)}.4
Case (b): Tc > x22. It is similar to case (a) and so there must be an orbit of5
subsystem S2 tangent to the line x = Tc at point B shown in Fig.3, which we also6
denoted as Γ4. The definition of the curve Υ is also the same to case (a). In such a7
case, equilibrium E11 is a regular equilibrium which is a center and locally stable8
within the region DΓ1
S1
. Any orbit in the region DΓ4 is free from switching and9
tends to (∞, 0) along subsystem S2. Similarly, any orbit initiating from the region10
DΥ \DΓ1
S1
will first approach point B and then tend to (∞, 0) along the orbit Γ4l11
as shown in Fig.3. So when Tc > x22, the global dynamics of system (2) can be12
concluded as following results.13
Theorem 3 If Tc > x22 holds true, then the equilibrium E11 is a center and14
locally stable in DΓ1
S1
. All other orbits starting from R2+ \DΓ1
S1
will tend to (∞, 0).15
And the global attractor of the switching system (2) is DΓ1
S1
∪ {(∞, 0)}.16
Case (C): x23 < Tc < x22. In this scenario, there would be two intersection17
points between the homoclinic orbit Γ1S2 and line x = Tc denoted by E5 = (Tc, y5)18
and E6 = (Tc, y6) respectively, shown in Figs.4-8. It follows from the first integral19
of subsystem S2 and equations (9) and (10) that y5 and y6 can be calculated20
respectively as21
y5 = − r−ε1β W
[
0,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h21ω)
(r−ε1)ω
)]
(13)
and22
y6 = − r−ε1β W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h21ω)
(r−ε1)ω
)]
(14)
with h21 = H2(x22, y22).23
According to the topological structure of subsystem S1, there must be an orbit24
Γ7 of subsystem S1 initiating from the point E5, and it intersects with line x = Tc25
at another point E7 = (Tc, y7). And we can conclude that y7 > y6 holds true by26
14
using the Lemma 2 (see appendix B). It follows from the first integral of subsystem1
S1 and the equation (8) that y7 can be solved as:2
y7 = − rβW
[
−1,−β
r
exp
(
ρln(1+ωTc)−δωln(Tc)−µωTc+h12ω)
rω
)]
(15)
with h12 = H1(Tc, y5).3
Similarly, there must exist an orbit of subsystem S2 passing through the point4
E7, which is denoted by Γ
8. Then the curve Υ for this scenario can be defined as5
Γ8 ∪ Ê7E5|S1 ∪ ̂E5E22|S2 ∪ Γ2S2 . In the following we specify four subcases in terms of6
relationships among Tc, x21, x11 and x12.7
Subcase (C1): Suppose x23 < Tc < x21 holds true. Then there exists a closed8
orbit ζ1 of subsystem S2 which is tangent to line x = Tc at the point B shown in9
Fig.4. As we have discussed in section 3, B is a boundary point of the sliding10
domain which is also a visible Σ−fold point. Therefore the closed orbit ζ1 is a11
touching cycle of the Filippov system (2) (see (Kuznetsov et al., 2003)). Define the12
region inside the cycle ζ1 as Dζ1 . The equilibrium E21 is a regular equilibrium13
which is a center and locally stable in Dζ1 . Then we will show that all the orbits in14
DΥ \Dζ1 tend towards the touching cycle ζ1. To verify this conclusion, we need to15
consider two diﬀerent situations:16
When y6 < r/β, any orbit initiating from DΥ \Dζ1 either directly reaches the17
segment BA or enters into the region S1 by crossing the segment AE7 as shown in18
Fig.4(a). Note that the orbit of subsystem S1 initiating from AE7 either directly19
reaches the segment BA or enters into the region S2 by crossing the segment E5B,20
follows the dynamics of subsystem S2, and finally reaches the segment BA.21
Therefore, all the orbits in the region DΥ \Dζ1 will first reach the segment BA.22
Furthermore, any trajectory initiating from the segment BA will slide down to23
point B, and then remain at the touching cycle ζ1, due to dy/dt = QS < 0. This24
verified the conclusion under this situation.25
When y6 > r/β, similarly, any orbit starting from the region DΥ \Dζ1 (see26
Fig.4(b)) will (i) directly reach the segment BA, or (ii) enter into the region S1 by27
crossing the segment AE7, and follow the dynamics of system S1 then approach the28
segment BA or enter to the region S2 by crossing the segment E5B, and follow the29
15
dynamics of system S2 then reaches to the segment BA or enter the region S1 again1
by crossing the segment AE7 and then it follows Lemma 2 (see Appendix B) that2
we can deduce that it will finally reach the segment BA. Moreover it is similar to3
the former case that any trajectory initiating from the segment BA will slide down4
and reach the touching cycle ζ1. This verified the conclusion for this situation.5
Next, we consider where the orbits initiating from the region R2+ \DΥ go.6
Definitely, any orbit initiating from the region between Γ2S2 and Γ
3
S2
is free from7
switching, follows the dynamics of system S2 and finally tends to (∞, 0). Any orbit8
starting from the region above the curve Υ firstly reaches the switching line on9
{(Tc, y)|y > y7}, enters the region S1 and follows the dynamics of system S1, then10
crosses the switching line again on {(Tc, y)|0 < y < y5} and enters the region S211
again, finally tending to (∞, 0). Then we conclude that trajectories initiating from12
diﬀerent region will approach the diﬀerent states. It is more interesting to show13
the various simulations in Fig.5(a-b) in which all the parameter values are fixed as14
in Fig.4(a). It follows from Fig.5(a) that the viral load fluctuates at a certain level15
while (b) demonstrates that the viral load goes to infinity. Then the global16
dynamics of system (2) when x23 < Tc < x21 can be concluded as follows:17
Theorem 4 If x23 < Tc < x21 holds true, then system (2) has a touching cycle18
ζ1. The equilibrium E21 is a regular equilibrium which is a center and locally stable19
in Dζ1. The orbits initiating from the region DΥ \Dζ1 will tend towards the20
touching cycle ζ1, and the other orbits starting from R
2
+ \DΥ finally tend towards21
(∞, 0). The global attractor of the Filippov system (2) is Dζ1 ∪ {(∞, 0)}.22
Subcase (C2): Suppose x21 < Tc < x11 holds true, it follows from theorem 123
that there exists a pseudo-equilibrium Ec which is locally stable on the sliding24
domain. Fig.6 shows that the orbits starting from DΥ initially reach the switching25
segment BA, and then slide down or up to the pseudo-equilibrium Ec.26
Simultaneously, we have that all the other orbits will tend to (∞, 0). Further,27
Fig.5(c) illustrates that the viral load is successfully controlled and stabilizes at a28
level of Tc and (d) shows that the viral load goes to infinity. Then we have the29
16
following conclusion.1
Theorem 5 If x21 < Tc < x11 holds true, then there exists a2
pseudo-equilibrium Ec of system (2) which is locally asymptotically stable in DΥ.3
Any orbit initiating from R2+ \DΥ tends to (∞, 0). The global attractor of the4
Filippov system (2) is {Ec, (∞, 0)}.5
Subcase (C3): Suppose x11 < Tc < x12 holds true. Then there exists a closed6
orbit ζ2 of subsystem S1 which is tangent to line x = Tc at the point A. Based on7
the discussion in section 3, the point A is a boundary point while it is also a visible8
Σ−fold point of subsystem S1. Therefore, the closed orbit ζ2 is a touching cycle of9
system (2) (see (Kuznetsov et al., 2003)). Define the region bounded by the10
touching cycle ζ2 as Dζ2 . At this time, any orbit initiating from the segment BA11
will slide up and reach the point A. The global dynamics of the Filippov system12
(2) are similar to those of theorem 4. Here we conclude as follows:13
Theorem 6 If x11 < Tc < x12 holds true, then there also exists a touching14
circle ζ2. The equilibrium E11 is a regular equilibrium and is locally stable in Dζ2.15
Any orbit initiating from the region DΥ \Dζ2 finally tends to the touching cycle ζ2,16
all the other orbits starting from R2+ \DΥ will tend to (∞, 0). The global attractor17
of the Filippov system (2) is Dζ2 ∪ {(∞, 0)}.18
Subcase (C4): Suppose x12 < Tc < x22. Then the equilibrium E11 is a regular19
equilibrium, and there also exists a pseudo-equilibrium Ec which is stable on the20
sliding domain according to theorem 1. The global dynamics of the Filippov21
system (2) are similar to the case when x11 < Tc < x12, and we then omit the22
proof. So we have the following conclusion.23
Theorem 7 If x12 < Tc < x22 holds true, then the equilibrium E11 is a regular24
equilibrium which is also a center and locally stable in DΓ1
S1
. There also exists a25
pseudo-equilibrium Ec with any orbit starting from the region DΥ \DΓ1
S1
finally26
tending to it. All the other orbits starting from R2+ \DΥ will tend to (∞, 0). The27
global attractor of the Filippov system (2) is DΓ1
S1
∪ {Ec, (∞, 0)}.28
17
In summary, we have examined the global dynamics of the Filippov system (2).1
It has been shown that for relatively low or large level of threshold (i.e. Tc < x23 or2
Tc > x22) the Filippov system (2) behaves either like the controlled subsystem S23
or free subsystem S1. It indicates that the region DΓ1
S1
(or DΓ1
S2
) bounded by4
homoclinic orbit Γ1S1 (or Γ
1
S2
) is the only invariant set from which HIV virus load5
remains bounded. While for intermediate levels of threshold (i.e. x23 < Tc < x22),6
a new phenomenon was observed for this virus-guided therapy. In particular, we7
obtained a much bigger region DΥ bounded by the critical curve Υ from which8
HIV virus load can be maintained below a certain level, and hence we name the9
region DΥ as the controllable region. It is interesting to examine how the region10
DΥ change as the threshold Tc, elimination rate ε1 and growth rate of the eﬀector11
cells ε2 vary. Since the region DΥ increases with increasing x, we choose a certain12
constant and suﬃciently large value of x, say x = TΥ, such that the region is closed13
and can be evaluated.14
Without lose of generality, we assume that TΥ > x22 always holds true. Then the15
line x = TΥ divides the region DΥ into two subregions and we denote the left16
subregion as DLΥ. Simultaneously, there exists an intersection point of the curve Υ17
to the line y = r/β, denoted as EΥ = (xΥ, r/β) (shown in Fig.4-8) and xΥ satisfy18
the following equation19
− ρ
ω
ln(1 + ωxΥ) + δ ln xΥ + µxΥ + r ln(
r
β
)− r − h12 = 0. (16)
It follows from the first integral of the subsystems and the definition of the20
Lambert W function that we can calculate the area of region SDL
Υ
as follows21
SDL
Υ
=
∫ Tc
xΥ
(
r
β
(
W
[
0,−β
r
exp
(
ρ ln(1+ωx)−δω ln(x)−µωx+h12ω)
rω
)]
− W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωx)−δω ln(x)−µωx+h12ω)
r−ω
)]))
dx+∫ TΥ
Tc
(
r−ε1
β
(
W
[
0,− β
r−ε1
exp
(
ρ ln(1+ωx)−(δ−ε2)ω ln(x)−µωx+h21ω)
(r−ε1)ω
)]
− W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωx)−(δ−ε2)ω ln(x)−µωx+h22ω)
(r−ε1)ω
)]))
dx
(17)
where22
h12 = H1(Tc, y5), h21 = H2(x22, y22), h22 = H2(Tc, y7). (18)
18
Due to highly nonlinear properties of SDL
Υ
, we numerically investigate the variation1
in SDL
Υ
with parameters Tc, ε1, ε2. Fig.9(A-B) shows that for a given εi (i = 1, 2),2
SDL
Υ
initially increases and then turns to decline as the threshold Tc increases. This3
means that there exists an optimal threshold such that the area of the controllable4
region DLΥ maximizes and hence in such a scenario HIV virus is maximally5
controlled. It follows from Fig.9(C-D) that for a given threshold Tc, SDL
Υ
becomes6
large as ε1 or ε2 increases.7
Remark: Based on the above discussions, it is interesting to observe that8
several bifurcations occur if we let bifurcation parameter Tc increase and keep all9
other parameters fixed. As Tc increases and exceeds x23, a touching cycle appears.10
When Tc reaches x21, the touching cycle disappears, and the pseudo-equilibrium11
appears and coincides with the boundary equilibrium B of the sliding domain.12
Then system (2) with (3) undergoes a sliding grazing bifurcation and the boundary13
center bifurcation at Tc = x21. As Tc increases and exceeds x21, the14
pseudo-equilibrium Ec coincides with the boundary point A for Tc = x11 at which15
the boundary center bifurcation occurs. As Tc continuously increases, a touching16
cycle appears again and it will disappear at Tc = x12. When Tc exceeds x12 the17
pseudo-equilibrium Ec appears, and the pseudo-equilibrium will coincide with the18
boundary saddle point A at Tc = x12. Finally, when Tc = x22, the19
pseudo-equilibrium coincides with the boundary saddle point B and the system (2)20
undergoes a boundary saddle bifurcation.21
6 Biological implications and discussion22
Although the strategies of STIs of antiretroviral therapies have been proposed for23
clinical management of HIV infected patients, clinical studies on STIs failed to24
achieve a consistent conclusion for this strategy. Many researchers suggested that25
in order to evaluate the benefits and risks of STIs, long-term studies are necessary26
and the choice of threshold may be pivotal for successful STIs (Maggiolo et al.,27
2009; Danel et al., 2006; DART Trial Team , 2008; Hirschel and Flanigan, 2009).28
19
In this study we have proposed and analyzed a viral dynamic model with a1
piecewise control function concerning a threshold policy for an HIV management2
strategy. The proposed model extends the classic model by including a piecewise3
elimination rate of HIV virus and growth rate of eﬀector cells to represent therapy4
strategies (antiretroviral drugs and interleukin (IL)-2 treatment) being triggered5
once the HIV virus load exceeds a threshold level.6
We examined the sliding domain and the sliding dynamics of system (2), and7
then the global dynamics of system (2) is discussed by considering several diﬀerent8
cases. Note that the pseudo-equilibrium Ec is feasible and is locally asymptotically9
stable for x21 < Tc < x11 or x12 < Tc < x22. In particular, when Tc < x23 (or10
Tc > x22), the region DΓ1
S2
(DΓ1
S1
) bounded by the homoclinic orbit Γ1S2 (Γ
1
S1
) is an11
invariant set, all other orbits initiating from R2+ \DΓ1
S2
(R2+ \DΓ1
S1
) approach12
(∞, 0). When the threshold satisfies x23 < Tc < x22, the critical curve Υ consisting13
of several critical orbits was defined, by which the global dynamics of system (2)14
can easily be obtained. It has been shown that the orbits starting from DΥ either15
(i) approach the pseudo-equilibrium Ec (Fig.6) or (ii) approach or remain in the16
invariant set Dζi(i = 1, 2) (shown in Fig.4, 7), or (iii) approach the17
pseudo-equilibrium Ec or remain in invariant set DΓ1
S1
(Fig.8), depending on the18
threshold and initial data. In such a scenario, other orbits starting from R2+ \DΥ19
also approach (∞, 0). It is worth mentioning that choosing an appropriate20
threshold level for making the decision to trigger the intervention and for its21
suspension is crucial (Canchemez et al., 2009; Day et al., 2006; Wang and Xiao,22
2013; Tang and Liang, 2013; Xiao et al., 2012, 2015).23
It is important to emphasize that this policy led to interesting biological24
interpretations which can help us to develop an optimal treatment strategy. For a25
relatively low level of threshold Tc (e.g. Tc < x23), then orbits of the system (2)26
may finally either remain in the invariant set DΓ1
S2
or approach (∞, 0). This27
indicates that any patient whose initial viral loads and eﬀector cells lie in the28
region DΓ1
S2
could successfully maintain their viral loads less than a certain level29
under such a treatment regime. Whereas other patients, whose initial viral loads30
20
and eﬀector cells lie in the region R2+ \DΓ1
S2
, may fail to control the increase in the1
viral loads. For a relatively high level of threshold Tc (e.g. Tc > x22), it follows2
from Fig.3 that the dynamics of the switching system (2) are the same as those for3
subsystem S1. This means that therapy is actually not triggered when the4
threshold is relatively large.5
For an intermediate threshold (e.g. x23 < Tc < x22), any orbit initiating from DΥ6
remains bounded, which implies that the HIV viral loads can be controlled. It also7
implies that any patient with initial HIV virus and eﬀector cell populations in the8
region DΥ can maintain his/her HIV virus population less than a low level by9
carrying out HIV virus-guided therapy with a suitable threshold. Whereas,10
patients with initial HIV virus and eﬀector cell populations outside the region DΥ11
can not prevent their HIV virus loads from increasing to infinity. Therefore, region12
DΥ can be thought of as a controllable region. In such a scenario, for a previous13
given threshold Tc (therapy regime is fixed), diﬀerent patients may have very14
diﬀerent treatment outcomes. For a given intensity of therapy (ε1 and ε2 fixed)15
there is an optimal threshold such that the area of region DΥ maximizes (as shown16
in Fig.9(A-B)). This indicates that for a patient with an initial HIV virus load may17
or may not maintain the growth of HIV virus loads, depending on the threshold18
level. Therefore, an individualized therapy is suggested, which indicates that the19
optimal choice of a treatment strategy for a given patient should depend on HIV20
virus and eﬀector cell populations at outset and the proposed threshold level.21
When therapy is implemented continuously, system (2) is actually subsystem S222
and only those orbits starting from the invariant set DΓ1
S2
can be controllable.23
However, by using proper HIV virus-guided therapy strategy (i.e. for24
x23 < Tc < x22) the controllable region can be greatly enlarged. Moreover, it is25
worth mentioning that when x21 < Tc < x11 the pseudo-equilibrium Ec is an26
unique attractor within the region DΥ, in which the HIV virus stabilizes at the27
previously given value Tc. This suggests that proper combinations of threshold and28
initial HIV virus loads and eﬀector cell counts based on a threshold policy can29
either preclude the uninhibited growth of HIV virus or lead to the HIV virus30
21
decreasing to a previously chosen level.1
The work presented here is an approach to the dynamics of HIV management2
when plasma HIV-1 RNA-guided therapy is initiated. Our main results indicate3
that HIV viral loads could be maintained either below a certain level or stabilize at4
a previously given level or go to infinity (corresponding to the eﬀector cells5
vanishing), depending on the threshold level and the initial HIV virus load and6
eﬀector cell counts. This would explain why some clinical studies support the7
implementation of STIs while others do not, mainly due to various threshold levels8
or recruited patients with diﬀering initial HIV virus loads and eﬀector cell counts.9
Therefore, the findings suggest that it is essential to carefully choose the10
thresholds of plasma HIV-1 RNA copies and individualize the STIs for each11
patient based on their initial plasma HIV-1 RNA copies and eﬀector cell counts.12
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Appendix A1
(A1) The property of the Lambert W function2
The Lambert W function (Corless et al., 1996) is defined to be a multivalued3
inverse of the function z → zez satisfying4
LambertW(z) exp(LambertW(z)) = z.
And we denote it as W for simplicity. Note that the function z exp(z) has the5
positive derivative (z + 1) exp(z) when z > −1. Define the inverse function of6
z exp(z) restricted on the interval [−1,+∞) to be W (0, z). Similarly, we define the7
inverse function of z exp(z) restricted on the interval (−∞,−1] to be W (−1, z).8
The branch W (0, z) is defined on the interval [−e−1,+∞) and it is monotonically9
increasing with respect to z. And the branch W (−1, z) is defined on the interval10
[−e−1, 0) and it is a monotonically decreasing function with respect to z.11
(A2) The definition domain of y
S1
l and y
S1
u12
Let’s consider the following equation13
e−1 = −β
r
exp
(
ρ ln(1 + ωx)− δω ln(x)− µωx+ h1ω)
rω
)
,
and rearranging it gives14
ρ ln(1 + ωx)− δω ln(x) = µωx− h1ω + rω ln
(
re−1
β
)
.
Denote15
G1(x) = ρ ln(1 + ωx)− δω ln(x), G2(x) = µωx− h1ω + rω ln
(
re−1
β
)
,
then by simple calculations we have16
G′1(x) =
ρω
1 + ωx
− δω
x
, G′′1(x) = −
ρω2
(1 + ωx)2
+
δω
x2
.
Solving G′1(x) = 0 with respect to x, we get an extreme point, denoted by17
xG = δ/(ρ− δω), and xG > 0 holds true due to ρ− µ− δω > 0. Further, solving18
G′′1(x) = 0 yields two inflexion points, denoted by x
1
I and x
2
I , where19
27
x1I =
δω +
√
ρδω
ω(ρ− δω) , x
2
I =
δω −√ρδω
ω(ρ− δω)
with x1I < xG < x
2
I .1
Moreover, it is easy to see that limx→0+ G1(x) = +∞, and solving G′1(x) = G′2(x)2
with respect to x, yields two roots, which are exactly the first components of the3
two interior equilibria E11 and E12. Let4
l1 = H1(x11, y11), l2 = H1(x12, y12),
then the family of closed orbits of subsystem S1 is5
Γh = {(x, y)|H1(x, y) = h, l2 < h < l1}.
Furthermore, Γh converts to the equilibrium E11 as h→ l1, and Γh becomes the6
homoclinic cycle as h→ l2.7
Therefore, the two curves are tangent at x = x11 or x12. If we choose h as a8
bifurcation parameter, then the domains of two branches of yS1l and y
S1
u can be9
determined as follows:10
1. If l2 < h < l1, then there exist three intersect points between the two functions11
G1 and G2, denoted by xmin, xmid and xmax. In this case, the two branches of y
S1
l12
and yS1u are well defined for all x ∈ [xmin, xmid] ∪ [xmax,+∞) with yS1l < r/β < yS1u .13
2. If h ≤ l2 or h ≥ l1, then there is one intersect point between the two functions14
G1 and G2, denoted by xmin. In this situation, we have that the two branches of15
yS1l and y
S1
u are well defined for all x ∈ [xmin,∞) with yS1l < r/β < yS1u .16
Similar results for yS2l and y
S2
u can be obtained by using the same methods as17
above.18
Appendix B19
Lemma 2: If the solution trajectory initiating from the point P S2 = (Tc, y
S2
P )20
on the segment {(Tc, y) : y5 < y < (r − ε1)/β} first reaches the switching line21
x = Tc at P1 = (Tc, yP1) on the segment AE7 along the system S2, and enters the22
region S1 by crossing the switching line x = Tc, and then approaches the switching23
28
line x = Tc again at the point P2 = (Tc, y
S1
P ) on the segment1
{(Tc, y) : y5 < y < (r − ε1)/β} along the system S1, then we have yS2p < yS1P .2
Proof. It follows from the first integral of the two subsystems and equations (8)3
and (10), we have that4
yP1 = − r−ε1β W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h
S2
P1
ω)
(r−ε1)ω
)]
= − r
β
W
[
−1,−β
r
exp
(
ρ ln(1+ωTc)−δω ln(Tc)−µωTc+h
S1
P1
ω)
rω
)]
,
(B.1)
which indicates that5
W
[
−1,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h
S2
P1
ω)
(r−ε1)ω
)]
<
W
[
−1,−β
r
exp
(
ρ ln(1+ωTc)−δω ln(Tc)−µωTc+h
S1
P1
ω)
rω
)]
.
(B.2)
Then, according to the property of the Lambert W function, we have that6
−W
[
0,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h
S2
P1
ω)
(r−ε1)ω
)]
<
−W
[
0,−β
r
exp
(
ρ ln(1+ωTc)−δω ln(Tc)−µωTc+h
S1
P1
ω)
rω
)]
.
(B.3)
That is, we have7
− r−ε1
β
W
[
0,− β
r−ε1
exp
(
ρ ln(1+ωTc)−(δ−ε2)ω ln(Tc)−µωTc+h
S2
P1
ω)
(r−ε1)ω
)]
<
− r
β
W
[
0,− r
β
exp
(
ρ ln(1+ωTc)−δω ln(Tc)−µωTc+h
S1
P1
ω)
rω
)]
.
(B.4)
Then it follows from equations (7) and (9) that there is yS2P < y
S1
P . This completes8
the proof.9
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Table 1: The diﬀerent types of all possible equilibria of system (2)
Values of Tc E11 E12 E21 E22
x21 > Tc VE VE RE RE
x21 < Tc < x11 VE VE VE RE
x11 < Tc < x12 RE VE VE RE
x12 < Tc < x22 RE RE VE RE
x22 < Tc RE RE VE VE
Note that ‘RE’ denotes regular equilibrium and ‘VE’ represents virtual equilibrium
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Figure legend1
Figure 1:
The illustration of topological structure of the orbits of the subsystems. We2
denote the homoclinic orbit of the equilibrium Ei2 as Γ
1
Si
(i = 1, 2). And we denote3
the stable codimension-1 manifolds and the unstable codimension-1 manifolds with4
respect to Ei2 as Γ
2
Si
and Γ3Si (i = 1, 2), respectively. Here the curves are plotted5
using subsystem S1 and the parameter values as6
r = 1.8, β = 0.6, ω = 0.55, ρ = 0.8, µ = 0.23, δ = 0.3.7
Figure 2:
The topological structure of the Filippov system (2) when Tc < x23. All the8
parameter values are fixed as9
r = 2.6, β = 1, ρ = 0.5, ω = 0.1, µ = 0.23, δ = 0.5, ε1 = 0.8, ε2 = 0.1, Tc = 0.7.10
Figure 3:
The topological structure of the Filippov system (2) when Tc > x22. Here11
Tc = 10.5 and other parameters are fixed as those in Fig.2.12
31
Figure 4:
The topological structure of the Filippov system (2) when x23 < Tc < x21 with1
(a) showing y6 < r/β and (b) showing y6 > r/β. Here parameter Tc = 1.2, r = 2.62
in (a) and r = 2 in (b) and other parameters are fixed as those in Fig.2.3
Figure 5:
Solutions of the Filippov system (2) when x23 < Tc < x21 in subplot (a-b) and4
x21 < Tc < x11 in subplot (c-d). Here Tc = 1.2 in (a) and (b) with the initial5
conditions of (9, 3.2) and (9, 5) respectively, and Tc = 2.5 in (c) and (d) with the6
initial conditions of (9, 3.2) and (9, 5) respectively. All the other parameters are7
fixed as those in Fig.2.8
Figure 6:
The topological structure of the Filippov system (2) when x21 < Tc < x11. Here9
Tc = 2.5 and other parameters are fixed as those in Fig.2.10
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Figure 7:
The topological structure of the Filippov system (2) when x11 < Tc < x12. Here1
Tc = 5.5 and other parameters are fixed as those in Fig.2.2
Figure 8:
The topological structure of the Filippov system (2) when x12 < Tc < x22. Here3
Tc = 6.5 and other parameters are fixed as those in Fig.2.4
Figure 9:
(A) The curves of SDL
Υ
as Tc increases with ε2 are fixed as 0.1; (B) The curves of5
SDL
Υ
as Tc increases with ε1 are fixed as 0.8; (C) The curves of SDL
Υ
as ε1 increases6
where ε2 = 0.1; (D) The curves of SDL
Υ
as ε2 increases where ε1 = 0.8. All other7
parameters are fixed as r = 2.6, β = 1, ω = 0.1, ρ = 0.5, µ = 0.23, δ = 0.5, TΥ = 10.8
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